Nesta página
CRIS Curis, Inc. - Common Stock
NASDAQ · Biotechnology · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 14, 2026
$0,80
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$0,80mínima 52 sem
$34,80máxima 52 sem
Capitalização de Mercado (MRQ)
$2M
P/E (TTM)
-0.2
EPS (TTM)
$-3.92
Receita (TTM)
$4M
seus distintivos
Intervalo 52 Semanas
$1–$35
Classificação do Analista
BUY
Preço-Alvo
$43
P/E
-0.2
ROE
455.3%
Margem de Lucro Líquido
-490.3%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
CRIS Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$0.80
Capitalização de Mercado (MRQ)
$2M
P/E (TTM)
-0.2
EPS (TTM)
$-3.92
Receita (TTM)
$4M
ROE (TTM)
455.3%
Dívida/Capital
0.0
Intervalo 52 Semanas
$1–$35
CRIS Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Divisões de Ações
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 6 de Julho de 2026 | 1-for-20 | Reverso |
| 29 de Setembro de 2023 | 1-for-20 | Reverso |
| 30 de Maio de 2018 | 1-for-5 | Reverso |
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$9M2016-12-31 → 2025-12-31
EPS$-0.582019-12-31 → 2025-12-31
Fluxo de caixa livre·2016-12-31 → 2023-12-31
Margem líquida-490.3%2016-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | CRIS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | -0.2média 5A ≈37.2 | ≈37.2 | · | · | |
| P/S (TTM) | 0.4média 5A ≈207.6 | ≈207.6 | · | · | |
| P/B (MRQ) | 0.3média 5A ≈24.5 | ≈24.5 | · | · | |
| EV / EBITDA | 0.8média 5A ≈-68.8 | ≈-68.8 | · | · | |
| Price / Cash Flow (Preço / Fluxo de Caixa) | -0.0média 5A ≈-58.8 | ≈-58.8 | · | · | |
| EV / Revenue (EV / Receita) | -0.5média 5A ≈270.2 | ≈270.2 | · | · | |
| Price / Tangible Book (Preço / Valor Patrimonial Tangível) | 0.3média 5A ≈47.4 | ≈47.4 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | CRIS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Operacional (TTM) | -203.2%média 5A ≈-336.5% | ≈-336.5% | · | · | |
| EBITDA Margin (Margem EBITDA) | -60.5%média 5A ≈-336.5% | ≈-336.5% | · | · | |
| Margem de Lucro Líquido (TTM) | -490.3%média 5A ≈-344.4% | ≈-344.4% | · | · | |
| ROA (TTM) | -87.8%média 5A ≈-43.4% | ≈-43.4% | · | · | |
| ROE (TTM) | 455.3%média 5A ≈131.9% | ≈131.9% | · | · |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | CRIS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Debt / Equity (Dívida / Patrimônio Líquido) | 0.0média 5A ≈-0.4 | ≈-0.4 | · | · | |
| Índice de liquidez corrente (MRQ) | 0.5média 5A ≈3.9 | ≈3.9 | · | · | |
| Quick Ratio (Índice de Liquidez Seca) | 0.4média 5A ≈3.7 | ≈3.7 | · | · |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | CRIS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | -13.4%média 5A ≈-2.5% | ≈-2.5% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | -2.4%média 5A ≈-1.4% | ≈-1.4% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | -2.7% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | CRIS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.3média 5A ≈0.2 | ≈0.2 | · | · | |
| Receivables Turnover (Giro de Contas a Receber) | 5.6média 5A ≈4.0 | ≈4.0 | · | · | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$472.1K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-16.7%
Próximo relatório
Nov 04, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 14, 2026 | $-4.02 | $-8.00 | 49.7% |
| 31 de Março de 2026 | $-25.00 | $-8.16 | -206.4% | |
| 31 de Dezembro de 2025 | $-10.00 | $-9.18 | -8.9% | |
| 30 de Setembro de 2025 | $-9.80 | $-11.79 | 16.9% | |
| 30 de Junho de 2025 | $-13.60 | $-18.16 | 25.1% | |
| 31 de Março de 2025 | $-1.25 | $-1.21 | -3.2% | |
| 31 de Dezembro de 2024 | $-1.25 | $-1.39 | 9.9% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9M | $11M | $10M | $10M | $11M | $11M | $10M | $10M | $10M | $8M | $8M | $10M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | $18M | · | $14M | |
| SG&A Expense | $14M | $17M | $19M | $20M | $17M | $12M | $12M | $15M | $14M | $16M | $13M | $12M | |
| Operating Expenses | $42M | $55M | $58M | $63M | $53M | $36M | $34M | $40M | $60M | $66M | $64M | $26M | |
| Operating Income | $-6M | $-45M | $-48M | $-53M | $-42M | $-25M | $-24M | $-29M | $-50M | $-58M | $-56M | $-16M | |
| Interest Expense | · | · | · | · | $0 | $0 | $791.0K | $4M | $4M | $3M | $3M | $4M | |
| Interest Income | $316.0K | $2M | $3M | $1M | $211.0K | $63.0K | $614.0K | $684.0K | $513.0K | $406.0K | $277.0K | $165.0K | |
| Other Non-op | $-2M | $1M | $919.0K | $-4M | $890.0K | $22.0K | $-58.0K | $0 | $-4M | $-2M | $-2M | $-3M | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-8M | $-43M | $-47M | $-57M | $-45M | $-30M | $-32M | $-33M | $-53M | $-60M | $-59M | $-19M | |
| EPS (Basic) | $-0.58 | $-6.88 | $-8.96 | $-12.14 | $0.50 | $-0.61 | $-0.97 | · | · | · | · | · | |
| EPS (Diluted) | $-0.58 | $-6.88 | $-8.96 | $-12.14 | $0.50 | $-0.61 | $-0.97 | · | · | · | · | · | |
| Shares (Basic) | 13,164,032 | 6,306,284 | 5,293,294 | 4,669,626 | 91,569,154 | 48,670,381 | 33,180,516 | · | · | · | · | · | |
| Shares (Diluted) | 13,164,032 | 6,306,284 | 5,293,294 | 4,669,626 | 91,569,154 | 48,670,381 | 33,180,516 | · | · | · | · | · | |
| EBITDA | $-6M | $-45M | $-48M | · | $-42M | $-25M | $-24M | $-29M | $-50M | $-58M | $-56M | $-16M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $20M | $27M | $20M | $40M | $130M | $15M | $24M | $38M | $26M | $33M | $8M | |
| Short-term Investments | · | $0 | $30M | $66M | $76M | $39M | $5M | $634.0K | $22M | $18M | $49M | $42M | |
| Receivables | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Prepaid Expense | $2M | $3M | $2M | $4M | $3M | $1M | $1M | $827.0K | $989.0K | $1M | $1M | $489.8K | |
| Current Assets | $7M | $26M | $61M | $92M | $122M | $173M | $25M | $28M | $64M | $48M | $86M | $52M | |
| PP&E (Net) | $62.0K | $231.0K | $434.0K | $689.0K | $505.0K | $663.0K | $154.0K | $267.0K | $400.0K | $400.0K | $300.0K | $407.7K | |
| PP&E (Gross) | $913.0K | $1M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $851.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Other Non-current Assets | $2M | $2M | $3M | $2M | $0 | $3.0K | $3.0K | $2.0K | $3.0K | $3.0K | $51.0K | $67.5K | |
| Total Assets | $20M | $41M | $77M | $109M | $162M | $204M | $35M | $37M | $74M | $58M | $95M | $63M | |
| Accounts Payable | $6M | $3M | $3M | $3M | $6M | $4M | $4M | $3M | $5M | $6M | $4M | $2M | |
| Accrued Liabilities | $7M | $7M | $9M | $6M | $6M | $4M | $2M | $3M | $3M | $3M | $2M | $2M | |
| Current Liabilities | $14M | $19M | $22M | $10M | $13M | $10M | $7M | $13M | $14M | $14M | $11M | $10M | |
| Capital Leases | $428.0K | $2M | $1M | $3M | $4M | $5M | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $334.0K | $0 | $11.0K | $34.0K | $18.0K | $139.0K | $174.0K | |
| Total Liabilities | $15M | $47M | $58M | $62M | $72M | $74M | $69M | $42M | $50M | $28M | $30M | $33M | |
| Long-term Debt | · | · | · | · | · | $891.0K | $0 | $35M | $42M | $20M | $24M | $28M | |
| Total Debt | $0 | $8M | · | · | $0 | $557.0K | $0 | $35M | $42M | $20M | $24M | $28M | |
| Common Stock | $6.0K | $85.0K | $59.0K | $48.0K | $916.0K | $915.0K | $332.0K | $332.0K | $331.0K | $1M | $1M | $872.5K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $810M | |
| Retained Earnings | $-1.25B | $-1.24B | $-1.20B | $-1.15B | $-1.09B | $-1.05B | $-1.02B | $-985M | $-952M | $-899M | $-839M | $-780M | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $2M | $2M | $2M | $2M | |
| AOCI | · | $0 | $229.0K | $-186.0K | $-109.0K | $-3.0K | $0 | $0 | $-2.0K | $-4.0K | $28.0K | $-11.0K | |
| Stockholders' Equity | $5M | $-6M | $20M | $47M | $91M | $131M | $-34M | $-4M | $24M | $29M | $65M | $30M | |
| Liabilities + Equity | $20M | $41M | $77M | $109M | $162M | $204M | $35M | $37M | $74M | $58M | $95M | $63M | |
| Shares Outstanding | 646,537 | 8,487,818 | 5,894,085 | 4,830,464 | 91,645,369 | 91,502,461 | 33,241,793 | 33,159,253 | 32,831,380 | 141,124,025 | 128,990,378 | 86,030,811 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $169.0K | $203.0K | $255.0K | $233.0K | $158.0K | $144.0K | $125.0K | $177.0K | $235.0K | $193.0K | $200.0K | $200.0K | |
| Stock-based Comp | $4M | $6M | $6M | $7M | $5M | $3M | $3M | $4M | $5M | $4M | $4M | $3M | |
| Operating Cash Flow | $-27M | $-40M | $-38M | $-54M | $-38M | $-26M | $-26M | $-30M | $-48M | $-36M | $-30M | $-17M | |
| CapEx | · | · | $0 | $416.0K | $0 | $677.0K | $41.0K | $85.0K | $188.0K | $329.0K | $48.0K | $92.0K | |
| Investing Cash Flow | $2M | $29M | $38M | $33M | $-48M | $-49M | $-4M | $21M | $-4M | $30M | $-6M | $16M | |
| Stock Issued | $15M | $12M | $14M | $6M | $0 | $159M | $0 | $0 | $42M | $0 | $65M | $0 | |
| Net Stock Activity | $15M | $12M | $14M | · | $0 | $159M | · | $0 | $42M | $0 | $65M | $282.8K | |
| Financing Cash Flow | $10M | $3M | $8M | $867.0K | $-4M | $189M | $23M | $-6M | $64M | $-1M | $62M | $-1M | |
| Net Change in Cash | $-15M | $-7M | $7M | $-20M | $-90M | $114M | $-7M | $-15M | $12M | $-7M | $25M | $-2M | |
| Free Cash Flow | · | · | $-38M | · | $-38M | $-26M | $-26M | $-30M | $-49M | $-36M | $-30M | $-17M |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -60.5% | -408.3% | -482.2% | · | -395.0% | -229.8% | -243.5% | -281.3% | -502.7% | -771.1% | -716.9% | -161.1% | |
| Net Margin | -80.3% | -397.8% | -473.0% | · | -426.7% | -276.0% | -320.9% | -312.6% | -538.7% | -802.6% | -748.6% | -190.3% | |
| EBITDA Margin | -60.5% | -408.3% | -482.2% | · | -395.0% | -229.8% | -243.5% | -281.3% | -502.7% | -771.1% | -716.9% | -161.1% | |
| ROA | -24.8% | -73.2% | -50.9% | · | -24.8% | -25.0% | -88.6% | -58.7% | -81.1% | -79.1% | -74.9% | -26.2% | |
| ROE | 177.9% | 589.0% | -192.5% | · | -46.9% | -58.6% | 107.1% | 1755.5% | -199.5% | -128.8% | -125.1% | -50.0% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.5 | 1.4 | 4.5 | · | 9.1 | 17.1 | 3.8 | 2.1 | 4.6 | 3.6 | 7.9 | 5.2 | |
| Quick Ratio | 0.4 | 1.2 | 4.4 | · | 8.9 | 17.0 | 3.6 | 2.0 | 4.5 | 3.5 | 7.8 | 5.1 | |
| Debt / Equity | 0.0 | -1.3 | · | · | 0.0 | 0.0 | 0.0 | -7.9 | 1.7 | 0.7 | 0.4 | 1.0 | |
| LT Debt / Equity | · | · | · | · | · | · | 0.0 | -6.4 | 1.5 | 0.5 | 0.3 | 0.8 | |
| Interest Coverage | · | · | · | · | · | · | -30.8 | -7.5 | -12.5 | -20.9 | -17.0 | -4.2 |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | |
| Receivables Turnover | 5.6 | 3.6 | 3.5 | · | 3.4 | 3.4 | 3.3 | 3.5 | 3.6 | 3.3 | 3.9 | 5.7 |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.42 | $-0.71 | $3.34 | · | $0.99 | $1.43 | $-1.02 | $-0.14 | $0.15 | $0.21 | $0.50 | $0.35 | |
| Revenue / Share | $0.72 | $1.73 | $1.89 | · | $0.12 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-2.07 | $-6.27 | $-7.26 | · | $-0.41 | · | · | · | · | · | · | · | |
| Cash / Share | $0.39 | $2.36 | $4.53 | · | $0.44 | $1.42 | $0.46 | $0.71 | $0.23 | $0.18 | $0.26 | $0.09 | |
| EPS (TTM) | $-0.58 | $-6.88 | $-8.96 | $-12.14 | $0.50 | $-0.61 | $-0.97 | · | · | · | · | · |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -13.4% | 8.8% | -1.4% | -4.6% | -1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.4% | 0.80% | -2.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.7% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $11M | $10M | $10M | $11M | $11M | $10M | $10M | $10M | $8M | $8M | $10M | |
| Net Income TTM | $-8M | $-43M | $-47M | $-57M | $-45M | $-30M | $-32M | $-33M | $-53M | $-60M | $-59M | $-19M | |
| Market Cap | $13M | $26M | $75M | · | $8.72B | $14.99B | $1.13B | $458M | $11.49B | $43.47B | $37.54B | $12.90B | |
| Enterprise Value | $8M | $14M | · | · | $8.61B | $14.82B | $1.11B | $469M | $11.47B | $43.44B | $37.48B | $12.88B | |
| P/E | -1.7 | -0.4 | -1.4 | -0.9 | 190.4 | -268.5 | -35.1 | · | · | · | · | · | |
| P/S | 1.4 | 2.4 | 7.5 | · | 819.3 | 1383.3 | 113.0 | 43.9 | 1160.9 | 5774.7 | 4764.7 | 1311.0 | |
| P/B | 2.3 | -4.3 | 3.8 | · | 96.2 | 114.7 | -33.3 | -101.8 | 478.9 | 1485.2 | 581.9 | 433.3 | |
| P / Tangible Book | · | · | 7.0 | 28.3 | 106.8 | 123.2 | · | · | · | · | · | · | |
| P / Cash Flow | -0.5 | -0.7 | -2.0 | · | -231.9 | -582.3 | -43.1 | -15.2 | -237.6 | -1213.8 | -1255.8 | -767.5 | |
| P / FCF | · | · | -2.0 | · | -231.9 | -567.4 | -43.1 | -15.2 | -236.7 | -1202.7 | -1253.8 | -763.4 | |
| EV / EBITDA | -1.4 | -0.3 | · | · | -204.7 | -595.2 | -45.6 | -16.0 | -230.6 | -748.5 | -663.6 | -812.2 | |
| EV / FCF | · | · | · | · | -228.8 | -561.0 | -42.3 | -15.5 | -236.3 | -1202.0 | -1251.8 | -762.1 | |
| EV / Revenue | 0.8 | 1.2 | · | · | 808.4 | 1367.8 | 110.9 | 45.0 | 1159.1 | 5771.4 | 4757.3 | 1308.9 | |
| Earnings Yield | -58.6% | -224.8% | -70.3% | -110.4% | 0.53% | -0.37% | -2.9% | · | · | · | · | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $1M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | |
| SG&A Expense | $3M | $5M | $3M | $4M | $4M | $4M | $3M | $4M | $5M | $5M | $5M | $5M | $4M | $5M | $4M | $5M | |
| Operating Expenses | $10M | $12M | $9M | $10M | $11M | $13M | $12M | $13M | $15M | $15M | $15M | $15M | $14M | $14M | $13M | $15M | |
| Operating Income | $-10M | $-12M | $20M | $-7M | $-8M | $-10M | $-9M | $-11M | $-13M | $-12M | $-12M | $-12M | $-12M | $-12M | $-10M | $-13M | |
| Interest Income | $62.0K | $77.0K | $51.0K | $80.0K | $92.0K | $93.0K | $227.0K | $325.0K | $701.0K | $515.0K | $665.0K | $806.0K | $815.0K | $652.0K | $542.0K | $335.0K | |
| Other Non-op | $1M | $-13M | $-263.0K | $-805.0K | $-342.0K | $-459.0K | $-624.0K | $475.0K | $709.0K | $593.0K | $487.0K | $187.0K | $177.0K | $68.0K | $-1M | $-688.0K | |
| Net Income | $-9M | $-24M | $19M | $-8M | $-9M | $-11M | $-10M | $-10M | $-12M | $-12M | $-12M | $-12M | $-12M | $-12M | $-11M | $-13M | |
| EPS (Basic) | $-4.02 | $-1.25 | $1.84 | $-0.49 | $-13.61 | $-1.25 | $-1.10 | $-1.70 | $-2.03 | $-2.05 | $-1.97 | $-2.13 | $-2.47 | $-2.39 | $-8.96 | $-2.83 | |
| EPS (Diluted) | $-4.02 | $-1.25 | $1.84 | $-0.49 | $-13.61 | $-1.25 | $-1.10 | $-1.70 | $-2.03 | $-2.05 | $-1.97 | $-2.13 | $-2.47 | $-2.39 | $-8.96 | $-2.83 | |
| Shares (Basic) | 2,135,906 | 19,363,478 | · | 15,680,178 | 631,475 | 8,493,886 | · | 5,940,924 | 5,818,416 | 5,783,585 | · | 5,720,789 | 4,834,381 | 4,830,763 | · | 4,689,559 | |
| Shares (Diluted) | 2,135,906 | 19,363,478 | · | 15,680,178 | 631,475 | 8,493,886 | · | 5,940,924 | 5,818,416 | 5,783,585 | · | 5,720,789 | 4,834,381 | 4,830,763 | · | 4,689,559 | |
| EBITDA | $-10M | $-12M | · | $-7M | $-8M | $-10M | · | $-11M | $-13M | $-12M | · | $-12M | $-12M | $-12M | · | $-13M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $15M | $5M | $9M | $10M | $20M | $20M | $21M | $10M | $30M | $27M | $24M | $20M | $32M | $20M | $30M | |
| Short-term Investments | · | · | · | · | · | · | · | $0 | $18M | $11M | $30M | $44M | $44M | $40M | $66M | $69M | |
| Receivables | · | · | $0 | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | |
| Prepaid Expense | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $2M | $2M | $2M | $4M | $4M | $4M | |
| Current Assets | $7M | $17M | $7M | $14M | $14M | $25M | $26M | $27M | $35M | $46M | $61M | $73M | $68M | $78M | $92M | $106M | |
| PP&E (Net) | $46.0K | $54.0K | $62.0K | $98.0K | $130.0K | $172.0K | $231.0K | $246.0K | $308.0K | $370.0K | $434.0K | $497.0K | $561.0K | $625.0K | $689.0K | $780.0K | |
| PP&E (Gross) | · | · | $913.0K | · | · | · | $1M | · | · | · | $2M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $851.0K | · | · | · | $1M | · | · | · | $2M | · | · | · | $2M | · | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Total Assets | $19M | $30M | $20M | $28M | $29M | $39M | $41M | $42M | $50M | $62M | $77M | $90M | $84M | $95M | $109M | $123M | |
| Accounts Payable | $5M | $7M | $6M | $4M | $4M | $5M | $3M | $4M | $2M | $4M | $3M | $5M | $3M | $3M | $3M | $6M | |
| Accrued Liabilities | $7M | $7M | $7M | $7M | $7M | $6M | $7M | $8M | $7M | $6M | $9M | $7M | $6M | $4M | $6M | $7M | |
| Current Liabilities | $14M | $15M | $14M | $20M | $19M | $20M | $19M | $22M | $19M | $11M | $22M | $14M | $10M | $8M | $10M | $14M | |
| Capital Leases | $0 | $108.0K | $428.0K | $740.0K | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | |
| Total Liabilities | $14M | $17M | $15M | $42M | $43M | $46M | $47M | $51M | $51M | $53M | $58M | $60M | $58M | $58M | $62M | $67M | |
| Total Debt | · | · | · | $7M | $7M | $7M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $19.0K | $400.0K | $129.0K | $127.0K | $107.0K | $105.0K | $85.0K | $60.0K | $59.0K | $59.0K | $59.0K | $59.0K | $993.0K | $966.0K | $48.0K | $964.0K | |
| Retained Earnings | $-1.28B | $-1.27B | $-1.25B | $-1.27B | $-1.26B | $-1.25B | $-1.24B | $-1.23B | $-1.22B | $-1.21B | $-1.20B | $-1.18B | $-1.17B | $-1.16B | $-1.15B | $-1.14B | |
| AOCI | · | · | · | · | · | · | · | $0 | $42.0K | $338.0K | $229.0K | $103.0K | $2.0K | $9.0K | $-186.0K | $-479.0K | |
| Stockholders' Equity | $5M | $13M | $5M | $-15M | $-14M | $-7M | $-6M | $-9M | $-694.0K | $9M | $20M | $30M | $26M | $37M | $47M | $56M | |
| Liabilities + Equity | $19M | $30M | $20M | $28M | $29M | $39M | $41M | $42M | $50M | $62M | $77M | $90M | $84M | $95M | $109M | $123M | |
| Shares Outstanding | 1,949,041 | 39,978,693 | 12,928,853 | 12,733,853 | 10,708,393 | 10,462,250 | 8,487,818 | 6,020,259 | 5,904,278 | 5,894,085 | 5,894,085 | 5,885,313 | 99,344,798 | 96,617,898 | 4,830,464 | 96,398,360 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8.0K | $8.0K | $36.0K | $32.0K | $42.0K | $59.0K | $16.0K | $61.0K | $62.0K | $64.0K | $64.0K | $63.0K | $64.0K | $64.0K | $92.0K | $61.0K | |
| Stock-based Comp | $569.0K | $575.0K | $795.0K | $924.0K | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | |
| Operating Cash Flow | $-10M | $-9M | $-6M | $-6M | $-8M | $-7M | $-9M | $-6M | $-11M | $-13M | $-10M | $-8M | $-8M | $-12M | $-12M | $-13M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $52.0K | |
| Investing Cash Flow | $0 | $0 | $2M | $0 | $0 | $0 | $-428.0K | $18M | $-7M | $19M | $15M | $180.0K | $-3M | $26M | $3M | $4M | |
| Stock Issued | $-282.0K | $19M | $-119.0K | $6M | $-578.0K | $10M | $11M | $696.0K | $291.0K | $0 | $118.0K | $14M | $178.0K | $7.0K | $179.0K | · | |
| Net Stock Activity | · | $19M | · | · | · | $10M | · | · | · | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $-282.0K | $19M | $-119.0K | $4M | $-2M | $8M | $9M | $-2M | $-1M | $-2M | $-2M | $13M | $-852.0K | $-2M | $-1M | $5M | |
| Net Change in Cash | $-10M | $10M | $-4M | $-1M | $-10M | $285.0K | $-857.0K | $11M | $-20M | $3M | $2M | $5M | $-12M | $12M | $-10M | $-4M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-12M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -218.0% | -300.1% | -426.8% | · | -360.5% | -491.4% | -597.8% | · | -436.6% | -552.5% | -506.2% | · | -446.2% | |
| Net Margin | · | · | · | -243.4% | -312.6% | -446.0% | · | -344.3% | -463.6% | -569.3% | · | -430.0% | -544.4% | -503.2% | · | -470.6% | |
| EBITDA Margin | · | · | · | -218.0% | -300.1% | -426.8% | · | -360.5% | -491.4% | -597.8% | · | -436.6% | -552.5% | -506.2% | · | -446.2% | |
| ROA | -35.6% | -70.1% | · | -22.1% | -21.6% | -20.9% | · | -15.2% | -17.5% | -15.2% | · | -11.5% | -11.2% | -9.8% | · | -9.0% | |
| ROE | 184.7% | -793.4% | · | 66.0% | 117.1% | -743.7% | · | -96.8% | -92.5% | -51.6% | · | -28.5% | -27.1% | -20.5% | · | -16.8% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.5 | 1.1 | · | 0.7 | 0.7 | 1.2 | · | 1.2 | 1.8 | 4.1 | · | 5.4 | 7.0 | 9.7 | · | 7.7 | |
| Quick Ratio | 0.4 | 1.0 | · | 0.6 | 0.7 | 1.1 | · | 1.1 | 1.6 | 3.8 | · | 5.2 | 6.8 | 9.2 | · | 7.4 | |
| Debt / Equity | · | · | · | -0.5 | -0.5 | -1.1 | · | · | · | · | · | · | · | · | · | · |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 1.0 | 1.0 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 | 0.9 | 1.1 | · | 1.0 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.41 | $0.32 | · | $-1.15 | $-1.31 | $-0.63 | · | $-1.45 | $-0.12 | $1.61 | · | $5.03 | $0.26 | $0.38 | · | $0.58 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.20 | $0.22 | $0.28 | · | $0.49 | $0.44 | $0.36 | · | $0.50 | $0.02 | $0.02 | · | $0.03 | |
| Cash Flow / Share | · | $-0.46 | · | · | · | $-0.85 | · | · | · | $-2.29 | · | · | · | $-0.13 | · | · | |
| Cash / Share | $2.60 | $0.38 | · | $0.71 | $0.95 | $1.94 | · | $3.46 | $1.69 | $5.08 | · | $4.16 | $0.20 | $0.33 | · | $0.31 | |
| EPS (TTM) | $-3.92 | $-13.51 | · | $-16.45 | $-17.66 | $-6.08 | · | $-7.75 | $-8.18 | $-8.62 | · | $-15.95 | $-16.65 | $-14.35 | · | $-2.33 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $7M | · | $12M | $11M | $11M | · | $10M | $10M | $10M | · | $10M | $10M | $10M | · | $10M | |
| Net Income TTM | $-21M | $-21M | · | $-37M | $-39M | $-42M | · | $-45M | $-48M | $-48M | · | $-47M | $-48M | $-52M | · | $-59M | |
| Market Cap | $1M | $22M | · | $21M | $25M | $22M | · | $32M | $41M | $64M | · | $39M | $1.65B | $1.16B | · | $1.35B | |
| Enterprise Value | · | · | · | $19M | $22M | $9M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -2.7 | -0.8 | · | -2.0 | -2.6 | -6.9 | · | -13.9 | -16.9 | -25.2 | · | -8.3 | -19.9 | -16.7 | · | -120.2 | |
| P/S | 4.7 | 62.3 | · | 36.3 | 43.6 | 39.2 | · | 63.3 | 80.2 | 130.6 | · | 75.9 | 3231.7 | 2229.2 | · | 2592.8 | |
| P/B | 0.2 | 1.7 | · | -1.4 | -1.8 | -3.3 | · | -3.7 | -58.7 | 6.8 | · | 1.3 | 62.9 | 31.7 | · | 24.2 | |
| P / Tangible Book | · | 5.9 | · | · | · | · | · | · | · | 133.5 | · | 1.9 | 95.6 | 42.0 | · | 28.9 | |
| P / Cash Flow | · | -2.4 | · | · | · | -3.0 | · | · | · | -4.8 | · | · | · | -95.0 | · | · | |
| EV / Revenue | · | · | · | 36.1 | 43.3 | 38.1 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -37.7% | -122.8% | · | -49.5% | -38.1% | -14.5% | · | -7.2% | -5.9% | -4.0% | · | -12.1% | -5.0% | -6.0% | · | -0.83% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $9M | $11M | $10M | $10M | $11M |
| Margem Operacional % | -60.5% | -408.3% | -482.2% | · | -395.0% |
| Lucro líquido | $-8M | $-43M | $-47M | $-57M | $-45M |
| EPS Diluído | $-0.58 | $-6.88 | $-8.96 | $-12.14 | $0.50 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.0 | -1.3 | · | · | 0.0 |
| Índice de liquidez corrente | 0.5 | 1.4 | 4.5 | · | 9.1 |
| Índice de Liquidez Seca | 0.4 | 1.2 | 4.4 | · | 8.9 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | · | · | $-38M | · | $-38M |
Investidores institucionais (13F) 39 declarantes · $8.3M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
39
Valor detido
$8.3M
Novas posições
7
Posições encerradas
12
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 7 (-4 vs trimestre anterior) | 12 (+4 vs trimestre anterior) | 5 (-9 vs trimestre anterior) | 10 (+4 vs trimestre anterior) | -2.4M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Bleichroeder LP | $1.985.196 | 3.802.329 | 23,88% | Ações |
| Stonepine Capital Management, LLC | $1.729.292 | 3.312.185 | 20,80% | Ações |
| SPHERA FUNDS MANAGEMENT LTD. | $1.033.717 | 98.996 | 12,43% | Ações |
| Nantahala Capital Management, LLC | $1.033.171 | 1.978.876 | 12,43% | Ações |
| Cable Car Capital, LP | $696.134 | 1.333.334 | 8,37% | Ações |
| VANGUARD GROUP INC | $361.347 | 366.107 | 4,35% | Ações |
| CM Management, LLC | $287.155 | 550.000 | 3,45% | Ações |
| MORGAN STANLEY | $263.291 | 504.292 | 3,17% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $179.486 | 343.842 | 2,16% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $153.036 | 293.097 | 1,84% | Ações |
| M28 Capital Management LP | $148.741 | 284.889 | 1,79% | Ações |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $128.306 | 245.750 | 1,54% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $74.123 | 141.972 | 0,89% | Ações |
| XTX Topco Ltd | $56.470 | 108.160 | 0,68% | Ações |
| NORTHERN TRUST CORP | $50.054 | 95.870 | 0,60% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $32.189 | 61.664 | 0,39% | Ações |
| BlackRock, Inc. | $27.846 | 53.334 | 0,33% | Ações |
| Focused Wealth Management, Inc | $26.131 | 50.049 | 0,31% | Ações |
| STATE STREET CORP | $10.990 | 21.049 | 0,13% | Ações |
| FRANKLIN STREET ADVISORS INC /NC | $10.442 | 20.000 | 0,13% | Ações |
| LPL Financial LLC | $7.819 | 14.977 | 0,09% | Ações |
| MAVERICK CAPITAL LTD | $6.194 | 49.554 | 0,07% | Ações |
| Dauntless Investment Group, LLC | $5.222 | 10.001 | 0,06% | Ações |
| BARCLAYS PLC | $3.641 | 6.973 | 0,04% | Ações |
| Steward Partners Investment Advisory, LLC | $1.356 | 2.597 | 0,02% | Ações |
| OSAIC HOLDINGS, INC. | $785 | 1.510 | 0,01% | Ações |
| Axiom Investment Management LLC | $574 | 1.100 | 0,01% | Ações |
| GROUP ONE TRADING LLC | $235 | 450 | 0,00% | Ações |
| JPMORGAN CHASE & CO | $48 | 108 | 0,00% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $39 | 120 | 0,00% | Ações |
| WELLS FARGO & COMPANY/MN | $29 | 55 | 0,00% | Ações |
| CWM, LLC | $28 | 51 | 0,00% | Ações |
| UBS Group AG | $24 | 46 | 0,00% | Ações |
| GSA CAPITAL PARTNERS LLP | $12 | 22.760 | 0,00% | Ações |
| CIBC Private Wealth Group LLC | $10 | 6 | 0,00% | Ações |
| Blue Trust, Inc. | $2 | 4 | 0,00% | Ações |
| VIMA LLC | $2 | 3 | 0,00% | Ações |
| MPWM ADVISORY SOLUTIONS, LLC | $1 | 2 | 0,00% | Ações |
| ROYAL BANK OF CANADA | $0 | 63 | 0,00% | Ações |
Ativistas e proprietários de 5%+ 3 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Pessoa de relato não divulgada | 4 de Março de 2004 | · | Declaração inicial | · | SEC |
| Pessoa de relato não divulgada | 29 de Janeiro de 2004 | · | Declaração inicial | Investimento passivo | SEC |
| Pessoa de relato não divulgada | 4 de Junho de 2003 | · | Declaração inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 33 insiders · 17 diretores · 16 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| James E Dentzer | President & CEO | 7 de Julho de 2026 A | 148.730 | 0 | 0 | $0 |
| Ali Fattaey Ph.D. | President & CEO | 15 de Maio de 2018 A | 322.140 | 0 | 0 | $0 |
| Diantha Duvall | CFO | 7 de Julho de 2026 A | 77.707 | 0 | 0 | $0 |
| William Steinkrauss | Chief Financial Officer | 29 de Janeiro de 2022 A | · | 0 | 0 | $0 |
| Michael Gray | CFO | 27 de Maio de 2015 A | 107.304 | 0 | 0 | $0 |
| Mitchell Keegan | Vice-President | 7 de Janeiro de 2011 A | · | 0 | 0 | $0 |
| Jonathan B. Zung | CDO | 7 de Julho de 2026 A | 66.667 | 0 | 0 | $0 |
| Ahmed Hamdy MD | CMO | 20 de Março de 2026 C | 66.667 | 0 | 0 | $0 |
| Robert Martell | Head of Research & Development | 20 de Janeiro de 2023 A | 23.027 | 0 | 0 | $0 |
| David Tuck | Chief Medical Officer | 15 de Maio de 2018 A | 169.424 | 0 | 0 | $0 |
| Mani Mohindru | Chief Strategy Officer | 14 de Fevereiro de 2017 A | · | 0 | 0 | $0 |
| Jaye Viner | Chief Medical Officer | 27 de Maio de 2015 A | · | 0 | 0 | $0 |
| Mark Noel | VP, Tech Management | 2 de Maio de 2013 M | 27.540 | 0 | 0 | $0 |
| Changgeng Qian | VP, Research & Preclinical Dev | 7 de Janeiro de 2011 A | · | 0 | 0 | $0 |
| Mary Elizabeth Potthoff | VP and General Counsel | 31 de Maio de 2006 A | 0 | 0 | 0 | $0 |
| Lee L Rubin | VP of Research | 1 de Junho de 2005 A | 9.814 | 0 | 0 | $0 |
| Christopher U Missling | Sr. VP, Strategic Planning | 16 de Janeiro de 2004 M | 0 | 0 | 0 | $0 |
| Anne Elizabeth Borgman | Conselheiro | 7 de Julho de 2026 A | · | 0 | 0 | $0 |
| John Hohneker | Conselheiro | 7 de Julho de 2026 A | · | 0 | 0 | $0 |
| Marc Rubin | Conselheiro | 7 de Julho de 2026 A | 28.108 | 0 | 0 | $0 |
| Kenneth I Kaitin | Conselheiro | 7 de Julho de 2026 A | 11.407 | 1 | 0 | $5.500 |
| Martyn D Greenacre | Conselheiro | 7 de Julho de 2026 A | 26.089 | 0 | 0 | $0 |
| Lori Anne Kunkel | Conselheiro | 31 de Janeiro de 2022 A | 22.200 | 0 | 0 | $0 |
| James R Mcnab | Conselheiro | 5 de Maio de 2017 S | 50.000 | 0 | 0 | $0 |
| Kenneth Pienta | Conselheiro | 28 de Fevereiro de 2017 A | 30.000 | 0 | 0 | $0 |
| James R Tobin | Conselheiro | 26 de Janeiro de 2015 A | 144.921 | 0 | 0 | $0 |
| Susan B Bayh | Conselheiro | 17 de Janeiro de 2013 A | 25.000 | 0 | 0 | $0 |
| Joseph Davie MD PHD | Conselheiro | 7 de Janeiro de 2011 A | · | 0 | 0 | $0 |
| Stephen Carter | Conselheiro | 25 de Janeiro de 2008 A | · | 0 | 0 | $0 |
| Joseph M Davie | Conselheiro | 6 de Junho de 2007 A | 20.000 | 0 | 0 | $0 |
| Douglas Melton | Conselheiro | 23 de Agosto de 2006 A | 173.499 | 0 | 0 | $0 |
| Daniel R Passeri | · | 19 de Janeiro de 2016 A | 211.798 | 0 | 0 | $0 |
| Maurizio Voi | · | 17 de Janeiro de 2013 A | · | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 2 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
CRIS Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 10 analistas
COMPRA
Alvo mediano
$43.00
+5252,3%
2 20,0%
Compra forte
7 70,0%
Compra
1 10,0%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
3 analistas · 2026-10-01Alvo médio $42.67 +5210,8%
← Abaixo de todos os alvos
Preço atual $0.80
Mín$20.00
Média$42.67
Máx$65.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 14, 2026